Login to Your Account

U.S. Patent Disclosures

Friday, April 12, 2013
• Neuralstem Inc., of Rockville, Md., was issued a U.S. Patent notice of allowance for application No. 12/404,841, for a method that uses expanded spinal cord stem cells, including NSI-566 stem cells, for the treatment of amyotrophic lateral sclerosis, or Lou Gehrig's disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription